# Aesculap AG clinical trials: 105 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 105 trials with Aesculap AG as lead sponsor, 20 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Aesculap AG: 105 rows for $5.25, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/aesculap-ag

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 105
- Recruiting or not yet: 20
- Read on: November 19, 2026

## Trials

The 25 newest of 105, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 7, 2026 | NCT07753005 | HISTOACRYL® Used for Embolization of Thoracoabdominal Artery Bleeding | Aesculap AG | Observational | Not yet recruiting | Hemorrhage, Gastrointestinal Hemorrhage, Hemoptysis, Postpartum Hemorrhage | 176 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07753005) |
| July 6, 2026 | NCT07682909 | oneKNEE - Prospective, Non-interventional, Multicenter PMCF-Study | Aesculap AG | Observational | Not yet recruiting | Arthroplasty, Arthroplasty Replacement, Knee, Prosthetic Joint Infections of Knee, TKA Outcomes | 1,020 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07682909) |
| December 2, 2025 | NCT07258069 | Study On Histoacryl Used For Embolization Of Middle Meningeal Artery (MMA) In Chronic Subdural Hematoma (CSDH) | Aesculap AG | Observational | Recruiting | Subdural Hematoma, Subdural Hematoma, Chronic | 178 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07258069) |
| August 20, 2025 | NCT07132970 | Leakage Rate of Ileo-COlic Sutured Anastomosis After Right Hemicolectomy | Aesculap AG | Observational | Recruiting | Anastomotic Leak, Colon Cancer, Right Hemicolectomy | 249 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07132970) |
| May 7, 2025 | NCT06960018 | Clinical Study on the Safety and Efficacy of the Minimally Invasive Ennovate® Method for Pedicle Screw Placement | Aesculap AG | Not applicable | Recruiting | Cervical Spine Disease, Pain, Postoperative | 76 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06960018) |
| May 2, 2025 | NCT06955481 | Study to Evaluate the Performance of Navigated TKA With OrthoPilot® pheno4u TKA Level 1 | Aesculap AG | Observational | Recruiting | Osteoarthritis, Knee, Joint Diseases, Rheumatoid Arthritis of Knee, Posttraumatic Arthropathy | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06955481) |
| December 17, 2024 | NCT06737809 | IP-coated Revision Hip Implants | Aesculap AG | Not applicable | Recruiting | Peri-Prosthetic Joint Infection | 268 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06737809) |
| December 13, 2024 | NCT06732167 | Performance and Safety of Lyoplant® in Guided Bone Regeneration (GBR) in Oral Surgery | Aesculap AG | Not applicable | Recruiting | Bone Regeneration | 68 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06732167) |
| October 24, 2024 | NCT06657248 | Clinical Performance and Safety of the Unicompartmental Univation® XF Pro Implant | Aesculap AG | Observational | Recruiting | Gonarthritis, Degenerative Disease | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06657248) |
| October 9, 2024 | NCT06632301 | DEXA Bone Density Analysis of the CoreHip® Prosthesis System | Aesculap AG | Not applicable | Not yet recruiting | Primary Osteoarthritis, Cartilage Degeneration, Osteoarthritis, Hip, Inflammatory Arthritis, Osteonecrosis of Femoral... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06632301) |
| October 3, 2024 | NCT06626490 | Prospective Follow-up of the Prevision Hip Stem With Comparison of Different Implant Variants | Aesculap AG | Observational | Recruiting | Revision Total Hip Arthroplasty, Periprosthetic Fracture of Hip | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06626490) |
| August 9, 2024 | NCT06547138 | Pilot Study on the Effectiveness and Safety of OPTILENE® SILVER MESH ELASTIC in Prevention of Surgical Site Infection (SSI) and Incisional... | Aesculap AG | Observational | Not yet recruiting | Abdominal Aortic Aneurysm, Morbid Obesity | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06547138) |
| March 7, 2024 | NCT06298500 | Clinical Performance of HISTOACRYL® LAPFIX - CANNULA for Laparoscopic Inguinal Hernia Repair | Aesculap AG | Observational | Completed | Inguinal Hernia | 443 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06298500) |
| October 24, 2023 | NCT06097078 | Endoluminal Vacuum Therapy to Prevent Anastomotic Leakage After Esophagectomy Due to Esophageal Cancer | Aesculap AG | Observational | Active not recruiting | Esophageal Cancer, Esophagus Cancer, Anastomotic Leak | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06097078) |
| October 4, 2023 | NCT06065800 | STEELEX® Sternum Set + BONE WAX® + STEELEX® Electrode Set in Patients Undergoing Cardiac Surgery | Aesculap AG | Observational | Completed | Sternum Closure | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06065800) |
| September 28, 2023 | NCT06055946 | Symmcora® Long-term Bidirectional Barbed Suture for Anastomosis in Patients Undergoing Robot Assisted Radical Prostatectomy | Aesculap AG | Observational | Completed | Prostate Cancer | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06055946) |
| September 6, 2023 | NCT06024109 | Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy | Aesculap AG | Observational | Recruiting | Abnormal Uterine Bleeding, Endometriosis, Uterine Prolapse, Uterine Cancer, Ovarian Cancer, Fallopian Tube Cancer... | 132 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06024109) |
| August 8, 2023 | NCT05980442 | Comparative Study of Navigation-assisted OrthoPilot® Elite and Robotic-assisted MAKO® Total Knee Arthroplasty | Aesculap AG | Observational | Recruiting | Osteoarthritis, Knee, Joint Diseases, Rheumatoid Arthritis of Knee, Posttraumatic Arthropathy | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05980442) |
| August 1, 2023 | NCT05968443 | Dafilon® Suture Material in Patients Undergoing Ophthalmic Surgery | Aesculap AG | Observational | Completed | Eye Diseases | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05968443) |
| August 1, 2023 | NCT05966961 | Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery | Aesculap AG | Observational | Recruiting | Surgical Site Infection | 2,998 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05966961) |
| July 13, 2023 | NCT05944081 | Postmarket Clinical Follow-Up Study on Arcadius XP L® Interbody Fusion Device | Aesculap AG | Observational | Withdrawn | Chronic Low-back Pain, Degenerative Disc Disease, Spondylolysis Lumbar, Postdiscectomy Syndrome, Posttraumatic... | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05944081) |
| April 14, 2023 | NCT05813236 | NOVOSYN® Quick Versus MONOSYN® Quick Suture Material in Resective Periodontal Surgery | Aesculap AG | Not applicable | Recruiting | Gingivitis, Gingival Diseases, Periodontal Diseases | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05813236) |
| April 11, 2023 | NCT05807633 | Performance of Novosyn® in Patients Undergoing Uterus Closure in Cesarean Section | Aesculap AG | Observational | Completed | Cesarean Section Complications, Cesarean Section; Infection | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05807633) |
| September 21, 2022 | NCT05547984 | Ceramic Modular Dual Mobility in Primary Total Hip Arthroplasty (THA) | Aesculap AG | Not applicable | Recruiting | Coxarthrosis; Primary | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05547984) |
| August 22, 2022 | NCT05509972 | In-vivo Wear Behaviour of AS Coated Versus Uncoated Columbus® Total Knee Prosthesis | Aesculap AG | Observational | Terminated | Knee Arthritis, Knee Osteoarthritis, Primary Osteoarthritis of Knee Nos, Secondary Osteoarthritis of Knee Nos... | 7 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05509972) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1/2 | 1 |
| Phase 4 | 8 |
| Not applicable | 12 |
| Observational | 84 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 65 |
| Recruiting | 16 |
| Active not recruiting | 8 |
| Terminated | 6 |
| Withdrawn | 6 |
| Not yet recruiting | 4 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Arthritis, Rheumatoid | 11 |
| Joint Diseases | 9 |
| Intervertebral Disc Degeneration | 6 |
| Osteoarthritis, Knee | 6 |
| Femur Head Necrosis | 6 |
| Osteoarthritis, Hip | 5 |
| Osteoarthritis | 5 |
| Spondylolisthesis | 4 |
| Hip Fractures | 4 |
| Joint Instability | 3 |
| Prosthesis Failure | 3 |
| Prostatic Neoplasms | 3 |
| Surgical Wound Infection | 2 |
| Arthritis | 2 |
| Coronary Artery Disease | 2 |
| Aortic Valve Stenosis | 2 |
| Surgical Wound | 2 |
| Lacerations | 2 |
| Fractures, Bone | 2 |
| Gastrointestinal Neoplasms | 2 |
| Colonic Neoplasms | 2 |
| Wounds and Injuries | 2 |
| Rheumatic Fever | 2 |
| Appendicitis | 2 |
| Anastomotic Leak | 2 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Gluten free restaurants in the United States](https://specstream.ai/data/businesses/gluten-free-restaurants/united-states)
- [Livestock feed and supply stores in the United States](https://specstream.ai/data/businesses/livestock-feed-and-supply-stores/united-states)
- [Pest control companies in the United States](https://specstream.ai/data/businesses/pest-control-companies/united-states)
- [South African restaurants in the United States](https://specstream.ai/data/businesses/south-african-restaurants/united-states)
- [Wholesalers in the United States](https://specstream.ai/data/businesses/wholesalers/united-states)
- [Bathtub and sink repair companies in the United States](https://specstream.ai/data/businesses/bathtub-and-sink-repair-companies/united-states)
